Y-mAbs Therapeutics Inc.

6.18
-0.01 (-0.16%)
At close: Jan 22, 2025, 3:59 PM
6.19
0.08%
After-hours Jan 22, 2025, 04:41 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
Net Income -21.43M -95.57M -55.27M -119.34M -81.03M -43.27M -19.16M -17.06M
Depreciation & Amortization 735.00K 839.00K 782.00K 396.00K 166.00K 29.00K n/a n/a
Stock-Based Compensation 14.45M 25.60M 19.33M 16.14M 4.66M 1.97M 609.00K 258.00K
Other Working Capital -4.59M -3.44M 1.76M 2.59M 48.00K -1.31M 360.00K 2.52M
Other Non-Cash Items -1.26M 3.58M -62.01M 8.71M 43.00K 97.00K -63.00K 2.28M
Deferred Income Tax n/a n/a 1.90M -576.00K n/a n/a n/a n/a
Change in Working Capital -19.73M -10.37M -7.28M 3.44M 2.67M -47.00K 2.75M 3.35M
Operating Cash Flow -27.23M -75.92M -102.56M -91.23M -73.50M -41.23M -15.87M -11.17M
Capital Expenditures n/a n/a -967.00K -175.00K -1.97M -234.00K n/a n/a
Acquisitions n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies n/a n/a 62.01M -2.61M n/a n/a n/a n/a
Investing Cash Flow n/a n/a 61.04M -2.79M -1.97M -234.00K n/a n/a
Debt Repayment n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a -366.00K
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 100.00K 84.00K 589.00K 2.00M n/a -1.00M -258.00K n/a
Financial Cash Flow 100.00K 84.00K 108.31M 2.00M 134.70M 98.76M 89.59M 18.97M
Net Cash Flow -27.13M -75.80M 66.93M -92.50M 59.27M 57.36M 73.61M 7.81M
Free Cash Flow -27.23M -75.92M -103.52M -91.41M -75.46M -41.46M -15.87M -11.17M

Create Price Alert on YMAB

Your price alert will notify you when the stock price is above 6.18.

Add to Watchlist